摘要
背景:以往的研究表明,血浆性激素可能与阿尔茨海默病(阿尔茨海默病)的发病有关。然而,性激素和AD之间的关系仍不清楚。目的:系统评价和定量分析研究,观察血浆总睾酮(TT)、雌二醇(E2)、性激素结合球蛋白(SHBG)在AD患者中的水平。方法:检索MEDLINE、EMBASE、Cochrane图书馆,和PsycINFO®搜索2014年3月28日之前发表的研究。发表的研究报道,血浆TT、E2水平,和在AD中的性激素结合球蛋白和匹配控制纳入荟萃分析。结果:采用随机效应模型进行荟萃分析,连续表达结果作为AD与控制群体间的平均差异。95%置信区间(次)进行了计算。血浆中睾酮与雌二醇的AD和对照组之间的水平没有差异(TT MD -0.17 nmol/l, 95%CI -0.54, 0.20; E2 MD -1.16 pmol/l, 95%CI -9.85, 6.83)。与健康对照组相比,AD患者血浆性激素结合球蛋白水平显著提高(SHBG MD 12.94 nmol/l, 95%CI 2.68, 23.20)。结论:AD患者存在血浆SHBG水平较高的情况。血浆SHBG的上调显示初步支持性证据,SHBG与血浆中功能性激素的生物利用度可能与AD的发病机制有关。
关键词: 阿尔茨海默氏病,生物标志物,雌二醇,荟萃分析,性激素结合球蛋白,睾酮。
Current Alzheimer Research
Title:Testosterone, Estradiol, and Sex Hormone-Binding Globulin in Alzheimer’s Disease: A Meta-Analysis
Volume: 13 Issue: 3
Author(s): Jing Xu, Lei-Lei Xia, Ning Song, Sheng-Di Chen, Gang Wang
Affiliation:
关键词: 阿尔茨海默氏病,生物标志物,雌二醇,荟萃分析,性激素结合球蛋白,睾酮。
摘要: Background: Previous studies suggested that plasma sex hormones may be implicated in the pathogenesis of Alzheimer’s disease (AD). However, the relationship between sex hormones and AD remains unclear. Objective: To systematically review and quantitatively analyze studies observing plasma total testosterone (TT), estradiol (E2), and sex hormone-binding globulin (SHBG) levels among AD patients. Methods: Medline, EMBASE, the Cochrane Library, and PsycINFO® were searched for studies published prior to March 28th, 2014. Published studies that reported plasma levels of TT, E2, and SHBG in AD and matched controls were included in the present meta-analysis. Results: Meta-analysis was performed using the random effects model, expressing continuous outcomes as the mean difference (MD) between AD and control populations. The 95% confidence intervals (CI) were also calculated. No differences were found in plasma levels of TT and E2 between AD and matched controls (TT MD -0.17 nmol/l, 95%CI -0.54, 0.20; E2 MD -1.16 pmol/l, 95%CI -9.85, 6.83). Plasma levels of SHBG were significantly increased in AD patients compared to healthy controls (SHBG MD 12.94 nmol/l, 95%CI 2.68, 23.20). Conclusion: Patients with AD had higher plasma levels of SHBG. The up-regulated levels of plasma SHBG show preliminary supportive evidence that SHBG and the bioavailability of functional sex hormones in plasma may be linked to the pathogenesis of AD.
Export Options
About this article
Cite this article as:
Jing Xu, Lei-Lei Xia, Ning Song, Sheng-Di Chen, Gang Wang , Testosterone, Estradiol, and Sex Hormone-Binding Globulin in Alzheimer’s Disease: A Meta-Analysis, Current Alzheimer Research 2016; 13 (3) . https://dx.doi.org/10.2174/1567205013666151218145752
DOI https://dx.doi.org/10.2174/1567205013666151218145752 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Polyphenols: A Diverse Class of Multi-Target Anti-HIV-1 Agents
Current Drug Metabolism Inhibition of Tumor Angiogenesis by Antibodies, Synthetic Small Molecules and Natural Products
Current Medicinal Chemistry Leptin and the Ob-Receptor as Anti-Obesity Target: Recent In Silico Advances in the Comprehension of the Protein-Protein Interaction and Rational Drug Design of Anti- Obesity Lead Compounds
Current Pharmaceutical Design The Role of Statins in Preventing the Progression of Congestive Heart Failure in Patients with Metabolic Syndrome
Current Pharmaceutical Design Recent Patents on PCSK9: A New Target for Treating Hypercholesterolemia
Recent Patents on DNA & Gene Sequences Secondary Prevention of Atherothrombotic Cerebrovascular Events
Current Vascular Pharmacology Pediatric CKD and Cardivascular Disease
Cardiovascular & Hematological Disorders-Drug Targets Genomics and Natural Products: Role of Bioinformatics and Recent Patents
Recent Patents on Biotechnology Leptin as a Cardiac Pro-Hypertrophic Factor and its Potential Role in the Development of Heart Failure
Current Pharmaceutical Design Antipsoriatic Drug Development: Challenges and New Emerging Therapies
Recent Patents on Inflammation & Allergy Drug Discovery Inflammation and Chronic Heart Failure: From Biomarkers to Novel Anti-inflammatory Therapeutic Strategies
Medicinal Chemistry Effects of Insulin on the Vasculature
Current Vascular Pharmacology Alzheimers and Dementia in the Oldest-Old: A Century of Challenges
Current Alzheimer Research Myocardial Inflammation in Autoimmune Diseases: Investigation by Cardiovascular Magnetic Resonance and Endomyocardial Biopsy
Inflammation & Allergy - Drug Targets (Discontinued) Rheumatic Heart Disease: Pathogenesis and Vaccine
Current Protein & Peptide Science Treatment Strategies of Obsessive-Compulsive Disorder and Panic Disorder/Agoraphobia
Current Topics in Medicinal Chemistry Pulmonary Arterial Hypertension in HIV-infected Patients
Current Hypertension Reviews Chemotherapeutic Options for Colorectal Cancer Patients with Cardiovascular Diseases.
Reviews on Recent Clinical Trials A Review on the Sex Differences in Organ and System Pathology with Alcohol Drinking
Current Drug Abuse Reviews Current Biology of MTP: Implications for Selective Inhibition
Current Topics in Medicinal Chemistry